Integra Holdings
Overview
Integra Holdings is a healthcare investment company with an exclusive first right to examine the innovations and intellectual property emerging from the world-renowned Hebrew University of Jerusalem. With a focus on biopharmaceuticals and medical diagnostics and devices, Integra employs multidisciplinary teams of experts who work alongside inventors and take a hands-on approach to achieve commercial success. Integra provides know-how and support to its portfolio companies from inception to commercialization, while leveraging its extensive industry network cultivated over decades of experience.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Ayana Pharma | Oct 2011 | Seed | Co-investor |
| SpliSense | Apr 2024 | Grant | Co-investor |
| Nectin Therapeutics | May 2024 | VC Round | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Integra Holdings based?
Integra Holdings is headquartered in Jerusalem, Jerusalem District, Israel.
When was Integra Holdings founded?
Integra Holdings was founded in 2012.
How many portfolio companies does Integra Holdings have?
Integra Holdings has 4 portfolio companies in Caplight's dataset.
What are some companies in Integra Holdings's portfolio?
Portfolio companies visible on Caplight include Ayana Pharma, SpliSense, Nectin Therapeutics.
What was Integra Holdings's most recent investment shown here?
Integra Holdings's most recent investment in this portfolio sample was in Nectin Therapeutics in 2024.
What sectors does Integra Holdings focus on?
Integra Holdings focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does Integra Holdings focus on?
Integra Holdings typically invests at the MultiStage stage.